Here's what you need to know.
1. The company released its earnings on Aug. 3. It had a $0.27 earnings per share for the quarter, which was significantly lower than Thomson Reuters' $0.35 EPS estimate.
2. Four research analysts gave Entellus a "buy" rating.
3. During the quarter, Entellus earned $18.73 million.
4. Revenue was also up 23.3 percent on a year-over-year basis.
More orthopedic and spinal device news:
Alphatec CFO resigns; company cuts workforce by 20% & more company updates — 5 key points
